Summary
- Current Price
- As of today, ABBV price is $224.35, down -1.91% on
- Current Price All-Time High
- ABBV price is currently -8.36% below its historical high of $244.81 set on
- Market Cap
- ABBV current market cap is $397B, up +13.81% over the past 365 days
- PE Ratio
- ABBV current PE ratio is 94.78
- Revenue
- ABBV current annual revenue is $61.16B, up +8.57% year-over-year
- Next Earnings
- The next earnings release for ABBV is on
Profile
| Metric | Value |
|---|---|
| Full Name | AbbVie Inc. |
| Ticker | NYSE: ABBV |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | abbvie.com |
| Employees | 55,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $224.35 | |
| Price, 1D Change | -1.91% | |
| Market Cap | $397B | |
| TTM Dividend Yield | 2.96% | |
| PE Ratio | 94.78 | |
| Beta | 0.42 | |
| Revenue | $61B | |
| Revenue, 1Y Change | +8.57% | |
| EPS | $2.38 | |
| EPS, 1Y Change | -0.28% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $1.73 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $2.38 | |
| EPS Estimate | N/A | $14.57 |
| EPS Est. Change | N/A | +511.09% |
| Revenue | $61.16B | |
| Revenue Estimate | N/A | $67.11B |
| Revenue Est. Change | N/A | +9.73% |
| Current Price | $224.35 | |
| Price Target | - | $245.00 |
| Price Tgt. Change | - | +9.20% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $10.45 | $2.39 | -77.13% | |
| $9.94 | $2.38 | -76.02% | |
| $14.57 | N/A | +511.09% | |
| $15.99 | N/A | +570.81% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $56.04B | $56.33B | +0.52% | |
| $60.96B | $61.16B | +0.33% | |
| $67.11B | N/A | +9.73% | |
| $72.33B | N/A | +18.27% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +13.68% | |
| Price, 3Y | +48.27% | |
| Market Cap, 1Y | +13.81% | |
| Market Cap, 3Y | +48.10% | |
| Revenue, 1Y | +8.57% | |
| Revenue, 3Y | +5.35% | |
| EPS, 1Y | -0.28% | |
| EPS, 3Y | -64.03% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $224.35 | |
| SMA 200 | $211.12 | |
| SMA 200 vs Price | -5.90% | |
| SMA 50 | $223.82 | |
| SMA 50 vs Price | -0.24% | |
| Beta | 0.42 | |
| ATR | $6.34 | |
| 14-Day RSI | 50.26 | |
| 10-Day Volatility | 25.68% | |
| 1-Year Volatility | 26.76% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $1.73 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 2.92% | |
| Total Dividend | $6.56 | |
| Dividends Paid | - | |
| Payout Ratio | - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $61.16B | |
| EPS | $2.38 | |
| Gross Profit | $51.20B | |
| Gross Margin | 83.71% | |
| Operating Profit | $21.21B | |
| Operating Margin | 34.69% | |
| Net Income | $4.23B | |
| Net Margin | 6.92% | |
| EBITDA | - |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | - | |
| Current Ratio | - | |
| Quick Ratio | - | |
| - | ||
| F-Score | - | |
| Altman Z-Score | - |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 94.78 | |
| PS Ratio | 6.48 | |
| PB Ratio | - | |
| EV/EBITDA | - | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | - | |
| Cash & Equivalents | - | |
| Total Assets | - | |
| Current Assets | - | |
| Total Liabilities | - | |
| Current Liabilities | - | |
| Total Debt | $0.00 | |
| Short Term Debt | - | |
| Accounts Payable | - |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $56.93B | |
| Operating Expenses | $29.98B | |
| Cost Of Goods Sold | $9.97B | |
| SG&A | $0.00 | |
| D&A | - | |
| Interest Expense | $0.00 | |
| Income Tax | $2.36B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | - | |
| CFI | - | |
| CFF | - | |
| Capex | - | |
| Free Cash Flow | - |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| UBS | → | |
| Morgan Stanley | → | |
| Evercore ISI Group | → | |
| Citigroup | → | |
| Wolfe Research | → | |
| Morgan Stanley | → | |
| HSBC | → | |
| UBS | → | |
| Piper Sandler | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
Screeners with ABBV
FAQ
What is the ticker symbol for AbbVie Inc.?
The ticker symbol for AbbVie Inc. is NYSE:ABBV
Does AbbVie Inc. pay dividends?
Yes, AbbVie Inc. pays dividends. The last payment was $1.73, with an ex-dividend date on January 16, 2026
What sector is AbbVie Inc. in?
AbbVie Inc. is in the Healthcare sector
What industry is AbbVie Inc. in?
AbbVie Inc. is in the General Drug Manufacturers industry
What country is AbbVie Inc. based in?
AbbVie Inc. is headquartered in United States
When did AbbVie Inc. go public?
AbbVie Inc. initial public offering (IPO) was on January 2, 2013
Is AbbVie Inc. in the S&P 500?
Yes, AbbVie Inc. is included in the S&P 500 index
Is AbbVie Inc. in the NASDAQ 100?
No, AbbVie Inc. is not included in the NASDAQ 100 index
Is AbbVie Inc. in the Dow Jones?
No, AbbVie Inc. is not included in the Dow Jones index
When was AbbVie Inc. last earnings report?
AbbVie Inc.'s most recent earnings report was on February 4, 2026
When does AbbVie Inc. report earnings?
The next expected earnings date for AbbVie Inc. is May 1, 2026
Data Sources & References
- ABBV Official Website www.abbvie.com
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- ABBV Profile on Yahoo Finance finance.yahoo.com/quote/ABBV
- ABBV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abbv